414 related articles for article (PubMed ID: 15301866)
1. HLA genotypes in Turkish patients with myasthenia gravis: comparison with multiple sclerosis patients on the basis of clinical subtypes and demographic features.
Dönmez B; Ozakbas S; Oktem MA; Gedizlioglu M; Coker I; Genc A; Idiman E
Hum Immunol; 2004 Jul; 65(7):752-7. PubMed ID: 15301866
[TBL] [Abstract][Full Text] [Related]
2. HLA antigens and susceptibility to myasthenia gravis.
Matej H; Nowakowska B; Kałamarz M; Paradowski B; Podemski R; Brzecki A
Arch Immunol Ther Exp (Warsz); 1987; 35(6):795-801. PubMed ID: 3508039
[TBL] [Abstract][Full Text] [Related]
3. HLA system affects the age-at-onset in chronic myeloid leukemia.
Oguz FS; Kalayoglu S; Diler AS; Tozkir H; Sargin D; Carin M; Dorak MT
Am J Hematol; 2003 Aug; 73(4):256-62. PubMed ID: 12879429
[TBL] [Abstract][Full Text] [Related]
4. [Disseminated sclerosis. Possible correlation between clinical forms and HLA groups (author's transl)].
Madigand M; Fauchet R; Oger J; Sabouraud O
Nouv Presse Med; 1981 Jun; 10(28):2349-52. PubMed ID: 7267340
[TBL] [Abstract][Full Text] [Related]
5. [Characteristics of histocompatibility antigens distribution in patients with multiple sclerosis].
Shiralieva RK; Guseĭnova KA
Klin Med (Mosk); 1998; 76(1):19-20. PubMed ID: 9532908
[TBL] [Abstract][Full Text] [Related]
6. HLA class I and class II polymorphism in the population of Rijeka, Croatia.
Crnić-Martinović M; Vujaklija-Stipanović K; Ristić S; Fućak M; Kapović M; Weiner M; Sepcić J
Coll Antropol; 2002 Jun; 26(1):69-75. PubMed ID: 12137325
[TBL] [Abstract][Full Text] [Related]
7. HLA-antigen frequencies in patients with progressive systemic sclerosis and morphea.
Kühnl P; Sibrowski W; Kalmar G; Holzmann H; Sollberg S; Böhm BO
Beitr Infusionsther; 1990; 26():287-9. PubMed ID: 1703854
[TBL] [Abstract][Full Text] [Related]
8. [Subgroups of myasthenia gravis. Association of the early form with HLA B8/DR3].
Scherbaum WA; Schumm F
Dtsch Med Wochenschr; 1983 Aug; 108(31-32):1218. PubMed ID: 6575909
[No Abstract] [Full Text] [Related]
9. [Gene frequency and haplotypes of the HLA system in the Panamanian population].
Vernaza-Kwiers AA; de Gómez IJ; Díaz-Isaacs M; Cuero CJ; Pérez Guardia E; Moreno Saavedra M
Rev Med Panama; 1995 Sep; 20(3):116-23. PubMed ID: 8668821
[TBL] [Abstract][Full Text] [Related]
10. [Immunogenetics of myasthenia gravis. Significance of HLA-, complement and Cm gene systems for clinical and immunologic parameters].
Grosse-Wilde H; Toyka KV; Besinger UA; Doxiadis I; Heininger K; Hömberg M; Hömberg V; Hohlfeld R; Fateh-Moghadam A; Jungwirth J; Kreeb G; Vögeler U
Dtsch Med Wochenschr; 1983 May; 108(18):694-700. PubMed ID: 6839994
[TBL] [Abstract][Full Text] [Related]
11. Cerebral cavernomas and human leukocyte antigens: preliminary clinical results.
Sanus GZ; Hanimoglu H; Tanriverdi T; Yilmaz E; Ak H; Ulu MO; Kafadar AM; Canbaz B; Kaynar MY
Surg Neurol; 2007 Aug; 68(2):164-6; discussion 167. PubMed ID: 17662350
[TBL] [Abstract][Full Text] [Related]
12. The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis population.
Silva AM; Pereira C; Bettencourt A; Carvalho C; Couto AR; Leite MI; Marta M; Freijo M; Costa PP; Mendonça D; Monteiro L; Armas JB; Martins B
J Neurol Sci; 2007 Jul; 258(1-2):69-74. PubMed ID: 17412364
[TBL] [Abstract][Full Text] [Related]
13. Immunogenetic heterogeneity and associated autoimmune disorders in myasthenia gravis: a population-based survey in the province of Ferrara, northern Italy.
Tola MR; Caniatti LM; Casetta I; Granieri E; Conighi C; Quatrale R; Monetti VC; Paolino E; Govoni V; Pascarella R
Acta Neurol Scand; 1994 Nov; 90(5):318-23. PubMed ID: 7887131
[TBL] [Abstract][Full Text] [Related]
14. HLA class I and class II polymorphisms in Saudi patients with myasthenia gravis.
Hajeer AH; Sawidan FA; Bohlega S; Saleh S; Sutton P; Shubaili A; Tahan AA; Al Jumah M
Int J Immunogenet; 2009 Jun; 36(3):169-72. PubMed ID: 19490212
[TBL] [Abstract][Full Text] [Related]
15. Analysis of HLA class I-II haplotype frequency and segregation in a cohort of patients with advanced stage ovarian cancer.
Gamzatova Z; Villabona L; van der Zanden H; Haasnoot GW; Andersson E; Kiessling R; Seliger B; Kanter L; Dalianis T; Bergfeldt K; Masucci GV
Tissue Antigens; 2007 Sep; 70(3):205-13. PubMed ID: 17661908
[TBL] [Abstract][Full Text] [Related]
16. HLA associations with multiple sclerosis in Sicily and Malta.
Elian M; Alonso A; Awad J; Dean G; Okoye R; Sachs J; Savettieri G; Vassallo L; Festenstein H
Dis Markers; 1987 Jun; 5(2):89-99. PubMed ID: 3509722
[TBL] [Abstract][Full Text] [Related]
17. Strong association of MuSK antibody-positive myasthenia gravis and HLA-DR14-DQ5.
Niks EH; Kuks JB; Roep BO; Haasnoot GW; Verduijn W; Ballieux BE; De Baets MH; Vincent A; Verschuuren JJ
Neurology; 2006 Jun; 66(11):1772-4. PubMed ID: 16769963
[TBL] [Abstract][Full Text] [Related]
18. Association with HLA DQ of early onset myasthenia gravis in Southeast Texas region of the United States.
Deitiker PR; Oshima M; Smith RG; Mosier D; Atassi MZ
Int J Immunogenet; 2011 Feb; 38(1):55-62. PubMed ID: 21108743
[TBL] [Abstract][Full Text] [Related]
19. Correlation of thymic pathology with HLA in myasthenia gravis.
Machens A; Löliger C; Pichlmeier U; Emskötter T; Busch C; Izbicki JR
Clin Immunol; 1999 Jun; 91(3):296-301. PubMed ID: 10370374
[TBL] [Abstract][Full Text] [Related]
20. HLA alleles and haplotypes in the east Black Sea Turkish population.
Uçar F; Ovali E; Pakdemir A; Alver A; Gök I; Karti SS; Kalay E
Transplant Proc; 2004 Nov; 36(9):2610-4. PubMed ID: 15621102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]